OPGEN INC
Company Information
Industry Services-Medical Laboratories
SIC Code 8071
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 9717 KEY WEST AVENUE, ROCKVILLE, MD, 20850
Mailing Address 9717 KEY WEST AVENUE, ROCKVILLE, MD, 20850
Phone 301-869-9683
Fiscal Year End 1231
EIN 061614015
Financial Overview
FY2024 FY
$5.20M
Revenue
$11.99M
Net Income
$9.86M
Total Assets
$13.44M
Total Liabilities
$1.31M
Cash & Equivalents
$2.44
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| DEF 14A Definitive proxy statement | February 6, 2026 | View on SEC |
| 8-K Current report of material events | January 16, 2026 | View on SEC |
| 8-K Current report of material events | December 23, 2025 | View on SEC |
| 3 Initial insider ownership report | December 10, 2025 | View on SEC |
| 8-K Current report of material events | December 5, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 19, 2025 | View on SEC |
| 10-Q Quarterly financial report | October 31, 2025 | View on SEC |
| 10-Q Quarterly financial report | October 1, 2025 | View on SEC |
| 10-K Annual financial report | August 21, 2025 | View on SEC |
| 4 Insider stock transaction report | July 30, 2025 | View on SEC |
Material Events
8-K Acquisition January 16, 2026
High Impact
- OPGEN is making a bold strategic move by acquiring iCapX Sdn. Bhd., propelling it into the high-growth fintech sector.
- This acquisition marks a substantial strategic pivot, diversifying OPGEN from its traditional diagnostics business.
8-K Leadership Change December 5, 2025
High Impact
- OPGEN INC executed a reverse stock split to meet NASDAQ listing requirements and improve stock perception.
- John Tan Honjian stepped down as CEO on December 1, 2025, but will continue as Chairman of the Board.
Related Companies
Companies in the same industry (SIC: 8071)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.